Literature DB >> 19214706

Glioblastoma in multiple sclerosis: a case report.

Giovanni Frisullo1, Agata Katia Patanella, Viviana Nociti, Alessandro Cianfoni, Raffaele Iorio, Assunta Bianco, Alessandro Marti, Pietro Attilio Tonali, Anna Paola Batocchi.   

Abstract

Cerebral tumor and multiple sclerosis (MS) relapses can show overlapping clinical and magnetic resonance imaging features. In a previous study we observed in relapsing MS patients increased T-bet, pSTAT1, and pSTAT3 expressions in circulating mononuclear cells. During the data analysis we observed that T-bet, pSTAT1, and pSTAT3 expression was not increased in circulating mononuclear cells from a relapsing-remitting (RR)MS patient with recent onset of new neurological signs due to glioblastoma multiforme. In conclusion, our patient represents an exemplary case which suggests that T-bet, pSTAT1, and pSTAT3 expression in peripheral blood mononuclear cells (PBMCs) might be useful to differentiate MS relapses from other noninflammatory diseases.

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19214706     DOI： 10.1007/s11060-009-9804-9

Source DB:  PubMed          Journal:  J Neurooncol        ISSN： 0167-594X            Impact factor:   4.130


  15 in total

Review 1.  Concurrence of multiple sclerosis and intracranial glioma. Report of a case and review of the literature.

Authors:  S Shuangshoti; G M Hjardermaal; Y Ahmad; J L Arden; M M Herman
Journal:  Clin Neuropathol       Date:  2003 Nov-Dec       Impact factor: 1.368

2.  Inhibition of lymphocyte responsiveness by a glial tumor cell-derived suppressive factor.

Authors:  T L Roszman; W H Brooks; L H Elliott
Journal:  J Neurosurg       Date:  1987-12       Impact factor: 5.115

3.  Anaplastic oligodendroglioma and gliomatosis type 2 in interferon-beta treated multiple sclerosis patients. Report of two cases.

Authors:  Sasa Sega; Alenka Horvat; Mara Popovic
Journal:  Clin Neurol Neurosurg       Date:  2005-12-27       Impact factor: 1.876

4.  Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 12-1997. A 50-year-old woman with multiple sclerosis and an enlarging frontal-lobe mass.

Authors:  D Paydarfar; S M de la Monte
Journal:  N Engl J Med       Date:  1997-04-17       Impact factor: 91.245

5.  Human glioma-induced immunosuppression involves soluble factor(s) that alters monocyte cytokine profile and surface markers.

Authors:  J P Zou; L A Morford; C Chougnet; A R Dix; A G Brooks; N Torres; J D Shuman; J E Coligan; W H Brooks; T L Roszman; G M Shearer
Journal:  J Immunol       Date:  1999-04-15       Impact factor: 5.422

6.  Interleukin-6-mediated autocrine growth promotion in human glioblastoma multiforme cell line U87MG.

Authors:  S Goswami; A Gupta; S K Sharma
Journal:  J Neurochem       Date:  1998-11       Impact factor: 5.372

7.  Messenger RNA expression of the immunosuppressive cytokine IL-10 in human gliomas.

Authors:  C Huettner; W Paulus; W Roggendorf
Journal:  Am J Pathol       Date:  1995-02       Impact factor: 4.307

Review 8.  A shift from adaptive to innate immunity: a potential mechanism of disease progression in multiple sclerosis.

Authors:  Howard L Weiner
Journal:  J Neurol       Date:  2008-03       Impact factor: 4.849

9.  Clinical and radiographic spectrum of pathologically confirmed tumefactive multiple sclerosis.

Authors:  C F Lucchinetti; R H Gavrilova; I Metz; J E Parisi; B W Scheithauer; S Weigand; K Thomsen; J Mandrekar; A Altintas; B J Erickson; F König; C Giannini; H Lassmann; L Linbo; S J Pittock; W Brück
Journal:  Brain       Date:  2008-06-05       Impact factor: 13.501

10.  Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis.

Authors:  W I McDonald; A Compston; G Edan; D Goodkin; H P Hartung; F D Lublin; H F McFarland; D W Paty; C H Polman; S C Reingold; M Sandberg-Wollheim; W Sibley; A Thompson; S van den Noort; B Y Weinshenker; J S Wolinsky
Journal:  Ann Neurol       Date:  2001-07       Impact factor: 10.422
View more
  5 in total

Review 1.  Janus head: the dual role of HLA-G in CNS immunity.

Authors:  Yu-Hwa Huang; Laura Airas; Nicholas Schwab; Heinz Wiendl
Journal:  Cell Mol Life Sci       Date:  2010-11-18       Impact factor: 9.261

2.  Genetic characterization of gliomas arising in patients with multiple sclerosis.

Authors:  Adam Khalil; Hilary Serracino; Denise M Damek; Douglas Ney; Kevin O Lillehei; B K Kleinschmidt-DeMasters
Journal:  J Neurooncol       Date:  2012-05-01       Impact factor: 4.130

3.  First Report of Tumor Treating Fields (TTFields) Therapy for Glioblastoma in Comorbidity with Multiple Sclerosis.

Authors:  Rebecca Kassubek; René Mathieu
Journal:  Brain Sci       Date:  2022-04-13

Review 4.  Concurrence of multiple sclerosis and brain tumors.

Authors:  Domenico Plantone; Rosaria Renna; Emilia Sbardella; Tatiana Koudriavtseva
Journal:  Front Neurol       Date:  2015-03-04       Impact factor: 4.003

Review 5.  Anaplastic astrocytoma mimicking progressive multifocal leucoencephalopathy: a case report and review of the overlapping syndromes.

Authors:  Ema Kantorová; Michal Bittšanský; Štefan Sivák; Eva Baranovičová; Petra Hnilicová; Vladimír Nosáľ; Daniel Čierny; Kamil Zeleňák; Wolfgang Brück; Egon Kurča
Journal:  BMC Cancer       Date:  2017-06-19       Impact factor: 4.430
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.